Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Ostrov joins NuLens board of directors
NuLens has named Gerald M. Ostrov to its board of directors.
Key Points
Herzeliya, Israel-NuLens Ltd. has named Gerald M. Ostrov to its board of directors.
Ostrov is the former company group chairman for the Johnson & Johnson Worldwide Vision Care Business.
NuLens researches, develops, and markets ophthalmic technologies and is working on a new accommodative IOL for patients with cataract and presbyopia.
Related Videos
Related Content
